• Clinical Trials - Brain tumor

    Study Objective Contact
    A Prospective, Multi-Center Trial Of NovoTTF-100A Together With Temozolomide Compared To Temozolomide Alone In Patients With Newly Diagnosed GBM [LCID Study Number: 2010-047] This study will compare the results of treatment using standard maintenance Temozolomide with a new experimental device, the NovoTTF100A versus maintenance Temozolomide alone following surgery and radiation therapy with adjuvant Temozolomide. Principal Investigator(s):
    Carlos A. David, MD

    For more information about this Research Study call 781-744-8027.

    Study Coordinator(s):
    Melissa Dunbar,
    Susan R. Christopher.
    NRG CC003: RANDOMIZED PHASE II/III TRIAL OF PROPHYLACTIC CRANIAL IRRADIATION WITH OR WITHOUT HIPPOCAMPAL AVOIDANCE FOR SMALL CELL LUNG CANCER [LCID Study Number: 2016-013CIRB] To determine if avoiding the hippocampus when preventively radiating the brain for patients with small cell lung cancer is as effective as standard preventive brain irradiation and if it reduces the likelihood of losing recall at six months. Principal Investigator(s):
    Klaudia U. Hunter, MD

    For more information about this Research Study call 781-744-8027.

    Study Coordinator(s):
    Donna Cossar,
    Shawn M. Regis, PhD.
    NRG-CC001, A Randomized, Phase III Trial Of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients With Brain Metastases [LCID Study Number: 2015-076CIRB] To determine if avoiding the hippocampus when treating brain metastases with whole-brain radiation delays the onset of neurocognitive failure (memory, word association, etc.). Principal Investigator(s):
    Klaudia U. Hunter, MD

    For more information about this Research Study call 781-744-8027.

    Study Coordinator(s):
    Donna Cossar,
    Shawn M. Regis, PhD.